Marksans-Pharma-Ltd Stock/Share Prices, Buy and Sell Marksans-Pharma-Ltd BSE Stocks

Market Snapshot

BSE Sensex: 49398.29 1.72%
BSE 500: 19049.36 1.79%
BSE 200: 6150.54 1.79%
BSE 100: 14671.2 1.76%
BSE Mid-Cap: 18952.06 2.31%
BSE Small-Cap: 18634.97 1.66%
BANKEX: 36730.19 1.95%
BSE IT Sector: 26108.92 0.71%
Nifty 50: 14521.15 1.68%
Nifty 500: 11981.85 1.75%
Nifty 200: 7522.75 1.76%
Nifty 100: 14632.2 1.68%
Nifty Midcap 100: 21969.2 2.32%
Nifty Small 100: 7395.65 1.72%
Nifty IT: 26043.5 0.49%
Nifty PSU Bank: 1940.7 2.69%

News:

Tata Metaliks Q3 PAT spurts 64...
CEAT spurts after strong Q3 ea...
Hatsun Agro jumps on stellar Q...
Alembic Pharma Q3 PAT rises 25...
Borosil Renewables Ltd leads l...

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

19 Jan 2021 | 03:59 PM

57.45

0.65 (1.14%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

193.11%

Return (1Y)

Beaten S&P BSE Healthcare by 139.45%
More Volatile

4.32%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 2.58%
Consistent Performer

8/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

News & Announcements

Marksans Pharma consolidated net profit rises 95.34% in the September 2020 quarter
74 days ago

Marksans Pharma consolidated net profit rises 95.34% in the September 2020 quarter

06 - Nov - 2020 12:00 AM | 74 days ago

Net profit of Marksans Pharma rose 95.34% to Rs 50.73 crore in the quarter ended September 2020 as against Rs 25.97 crore during the previous quarter ended September 2019. Sales rose 39.03% to Rs 356.47 crore in the quarter ended September 2020 as against Rs 256.40 crore during the previous quarter ended September 2019.
Particulars Quarter Ended
Sep. 2020 Sep. 2019 % Var.
Sales 356.47 256.40 39
OPM % 23.33 13.09 -
PBDT 84.89 38.64 120
PBT 65.90 33.66 96
NP 50.73 25.97 95
Powered by Capital Market - Live News
Marksans Pharma to table results
83 days ago

Marksans Pharma to table results

28 - Oct - 2020 12:00 AM | 83 days ago

Marksans Pharma will hold a meeting of the Board of Directors of the Company on 6 November 2020.
Powered by Capital Market - Live News
Board of Marksans Pharma appoints director
138 days ago

Board of Marksans Pharma appoints director

03 - Sep - 2020 12:00 AM | 138 days ago

The Board of Marksans Pharma at its meeting held on 03 September 2020 has appointed Dr. Meena Rani Surana, subject to approval of the members at a general meeting, as an Independent Woman Director of the Company for a term of five (5) consecutive years with effect from 3 September, 2020 not liable to retire by rotation.
Powered by Capital Market - Live News
Marksans Pharma to conduct AGM
153 days ago

Marksans Pharma to conduct AGM

19 - Aug - 2020 12:00 AM | 153 days ago

Marksans Pharma announced that the 28th Annual General Meeting (AGM) of the company will be held on 29 September 2020.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Marksans Pharma Ltd has decreased by -19.29% since past 3 Months
FII shareholding in Marksans Pharma Ltd has increased by 55.39% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2020	Sep. 2019	% Var.
Sales	356.47	256.40	39
OPM %	23.33	13.09	-
PBDT	84.89	38.64	120
PBT	65.90	33.66	96
NP	50.73	25.97	95

General Notifications

My Notifications

Research Notifications

Marksans Pharma Ltd NSE / BSE Pharmaceuticals, Small Cap

57.45 0.65 (1.14%)

News & Announcements

Price vs Volume

Stock Trivia

Marksans Pharma Ltd NSE / BSE
Pharmaceuticals, Small Cap

57.45

0.65 (1.14%)